Literature DB >> 19865060

Successful treatment of a critical burn patient with obstinate hyperglycemia and septic shock from pan-drug-resistant strains.

Shi-Chu Xiao1, Shi-hui Zhu, Zhao-Fan Xia, Bing Ma, Da-sheng Cheng.   

Abstract

BACKGROUND: The treatment of critical burn patients involves fluid resuscitation, homeostasis, prevention of infection, support and maintenance of organ functions, nutritional support, and wound repair. Correct management of these problems is a fierce challenge facing burn clinicians. This report presents a critical burn patient with obstinate hyperglycemia and septic shock from pan-drug-resistant strains. CASE REPORT: A 41-year-old female with a 96% total body surface area (TBSA) burn developed a series of severe complications during the course of treatment, including rare obstinate hyperglycemia and septic shock from pan-drug-resistant Acinetobacter baumanii. Several aspects of the applied treatment are emphasized: an immediate effort to close the wound, the appropriate use of antibiotics, and the extraordinarily large amounts of insulin for intensive therapy to control blood sugar.
CONCLUSIONS: The critical burn patient developed a series of severe complications during the course of treatment. Correct management of these complications is crucial to success in the treatment of such patients.

Entities:  

Mesh:

Year:  2009        PMID: 19865060

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  3 in total

1.  Previous burn injury predisposes mice to lipopolysaccharide-induced changes in glucose metabolism.

Authors:  Edward A Carter; Kasie W Paul; Sandra A Barrow; Alan J Fischman; Ronald G Tompkins
Journal:  J Burn Care Res       Date:  2012 Sep-Oct       Impact factor: 1.845

2.  Successful treatment of a patient with an extraordinarily large deep burn.

Authors:  Heng-yu Li; Shi-chu Xiao; Shi-hui Zhu; Guang-yi Wang; Guang-qing Wang; Shi-zhao Ji; Zhao-fan Xia
Journal:  Med Sci Monit       Date:  2011-04

3.  The wow factor as a determinant of funding for disorders of the skin.

Authors:  Terence J Ryan
Journal:  Mil Med Res       Date:  2015-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.